University of Oklahoma Health Sciences Center Gynecologic Oncology

Topics

• Endometrial and Cervical Cancer Treatments 247
• Ovarian cancer diagnosis and treatment 237
• PARP inhibition in cancer therapy 89
• Cervical Cancer and HPV Research 73
• Uterine Myomas and Treatments 29
• HER2/EGFR in Cancer Research 19
• Cancer Immunotherapy and Biomarkers 12
• BRCA gene mutations in cancer 11
• Ethics in Clinical Research 10
• Gestational Trophoblastic Disease Studies 8
• PI3K/AKT/mTOR signaling in cancer 8
• Angiogenesis and VEGF in Cancer 7

Most cited

1. Pembrolizumab plus Chemotherapy in Advanced Endometrial Cancer.

   The New England journal of medicine · 2023 · 633 citations · Robert Mannel, Cara Mathews

2. Recent advances and clinical applications of deep learning in medical image analysis.

   Medical image analysis · 2022 · 535 citations · Kathleen Moore, Robert Mannel

3. Mirvetuximab Soravtansine in FRα-Positive, Platinum-Resistant Ovarian Cancer.

   The New England journal of medicine · 2023 · 405 citations · Kathleen Moore

4. Durvalumab Plus Carboplatin/Paclitaxel Followed by Maintenance Durvalumab With or Without Olaparib as First-Line Treatment for Advanced Endometrial Cancer: The Phase III DUO-E Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2024 · 323 citations · Kathleen Moore

5. Overall Survival With Maintenance Olaparib at a 7-Year Follow-Up in Patients With Newly Diagnosed Advanced Ovarian Cancer and a BRCA Mutation: The SOLO1/GOG 3004 Trial.

   Journal of clinical oncology : official journal of the American Society of Clinical Oncology · 2023 · 420 citations · Paul DiSilvestro